Timed-sequential chemotherapy
Showing 1 - 25 of >10,000
Extensive Small Cell Lung Cancer Trial in Jinan (Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy)
Recruiting
- Extensive Small Cell Lung Cancer
- Adebelizumab+Carboplatin+Etoposide+Concurrent Radiotherapy
-
Jinan, Shan Dong, ChinaThe First Affiliated Hospital of Shandong First Medical Universi
Nov 6, 2023
Gastric, Colorectal Adenocarcinoma Trial in Shenyang (tislelizumab)
Not yet recruiting
- Gastric
- Colorectal Adenocarcinoma
-
Shenyang, Liaoning, ChinaLiaoning Cancer Hospital & Institute
Nov 1, 2023
Locally Advanced Gastric Adenocarcinoma, Chemo Effect Trial in Hanzhou (Docetaxel, Tegafur-Gimeracil-Oteracil)
Recruiting
- Locally Advanced Gastric Adenocarcinoma
- Chemotherapy Effect
-
Hanzhou, Zhejiang, ChinaGastrointestinal Department of Second Affiliated Hospital of Zhe
Apr 2, 2023
Metastatic Esophageal Squamous Cell Carcinoma Trial in Qingdao (TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1
Recruiting
- Metastatic Esophageal Squamous Cell Carcinoma
- TP regimen (cis-platinum ; Tocetaxel ) combined with PD-1 inhibitors（Sintilimab）
-
Qingdao, Shandong, China
- +1 more
Nov 13, 2023
Locally Advanced Rectal Cancer Trial (AK104 injection, TME surgery, Capecitabine)
Not yet recruiting
- Locally Advanced Rectal Cancer
- AK104 injection
- +3 more
- (no location specified)
Apr 4, 2023
Advanced Esophageal Squamous Carcinoma With Oligometastases Trial (simultaneous with radiotherapy, synchronous with
Not yet recruiting
- Advanced Esophageal Squamous Carcinoma With Oligometastases
- simultaneous with radiotherapy
- synchronous with radiotherapy
- (no location specified)
Nov 16, 2023
Refractory Leukemia Trial in Shanghai (CALGE-VEN- RIC-MBF)
Recruiting
- Refractory Leukemia
- CALGE-VEN- RIC-MBF
-
Shanghai, Shanghai, China
- +2 more
May 22, 2023
Hepatocellular Carcinoma, Chemo Effect, Chemotherapeutic Toxicity Trial in Guangzhou (Oxaliplatin,calcium folinic acid,
Recruiting
- Hepatocellular Carcinoma
- +2 more
- Oxaliplatin,calcium folinic acid, levofolinic acid, 5-FU
- +4 more
-
Guangzhou, Guangdong, ChinaSUN Yat-sen University Cancer Center
Sep 11, 2023
Acute Myeloid Leukemia, Myelodysplastic Syndrome Trial in Houston (procedure, drug, other)
Active, not recruiting
- Acute Myeloid Leukemia
- Myelodysplastic Syndrome
- Allogeneic Hematopoietic Stem Cell Transplantation
- +7 more
-
Houston, TexasM D Anderson Cancer Center
Oct 6, 2022
NSCLC Trial in Chongqing (procedure, drug, radiation)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- bronchial artery interventional therapy
- +3 more
-
Chongqing, Chongqing, ChinaDaping Hospital, Third Military Medical University
May 27, 2023
NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Carcinoma Breast
- Vinorelbine
- +4 more
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 29, 2022
Metastatic Colorectal Cancer Trial in Wuhan (SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab)
Recruiting
- Metastatic Colorectal Cancer
- SBRT Sequential CapeOX Regimen Combined With Bevacizumab and Sintilimab
-
Wuhan, Hubei, ChinaXianglin Yuan
Jun 24, 2022
Locally Advanced Nasopharyngeal Carcinoma Trial in Sichuan (low-dose radiotherapy)
Recruiting
- Locally Advanced Nasopharyngeal Carcinoma
- low-dose radiotherapy
-
Sichuan, Sichuan, ChinaLow-dose Radiotherapy and Neoadjuvant Chemotherapy Sequential Co
Aug 16, 2022
Chemo-induced Diarrhea Trial in Glendale (SK10, Placebo)
Recruiting
- Chemotherapy-induced Diarrhea
- SK10
- Placebo
-
Glendale, CaliforniaEarly Phase Clinical Unit (EPCU) - PAREXEL
Aug 30, 2023
Refractory Acute Myeloid Leukemia Trial in Paris (Sequential Packaging (SET), Transfusion graft, Prevention of GVHD)
Completed
- Refractory Acute Myeloid Leukemia
- Sequential Packaging (SET)
- +4 more
-
Paris, FranceService d'hématologie Clinique Hôpital Saint Antoine
Jul 22, 2022
Carcinoma, Non-Small Cell Lung Trial (sequential DEB-BACE and Arotinib and Tirelizumab, DEB-BACE alone)
Not yet recruiting
- Carcinoma, Non-Small Cell Lung
- sequential DEB-BACE and Arotinib and Tirelizumab
- DEB-BACE alone
- (no location specified)
May 14, 2022
Colorectal Cancer Trial (TACE protocol, Neoadjuvant Chemotherapy)
Not yet recruiting
- Colorectal Cancer
- TACE protocol
- Neoadjuvant Chemotherapy
- (no location specified)
Apr 15, 2022
Sequential Regorafenib Plus ICIs After HAIC for Advanced
Recruiting
- Hepatocellular Carcinoma
- Regorafenib combine with ICIs
-
Guangzhou, Guangdong, China
- +1 more
Oct 15, 2022
Nasopharyngeal Carcinoma Trial in Shanghai (gemcitabine and cisplatin (Induction and adjuvant chemo), IMRT, gemcitabine and
Recruiting
- Nasopharyngeal Carcinoma
- gemcitabine and cisplatin (Induction and adjuvant chemotherapy)
- +3 more
-
Shanghai, Shanghai, ChinaFudan University Shanghai Cancer Center
Feb 16, 2022
Acute Myeloid Leukemia, Chronic Myelomonocytic Leukemia-2, High Risk Myelodysplastic Syndrome Trial in New Haven, Baltimore,
Completed
- Acute Myeloid Leukemia
- +3 more
- Cytarabine
- +6 more
-
New Haven, Connecticut
- +2 more
Oct 10, 2020
Head and Neck Tumors Trial in Nanjing (Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU)
Recruiting
- Head and Neck Tumors
- Tislelizumab, Paclitaxel (albumin-bound type), Cisplatin, 5-FU
-
Nanjing, Jiangsu, ChinaDepartment of Oncology, Drum Tower Hospital, Nanjing University
Feb 24, 2023
Breast Cancer Trial in Lille (Consultation, Biological Test, Pelvic Ultrasound)
Active, not recruiting
- Breast Cancer
- Consultation
- +2 more
-
Lille, FranceCentre Oscar Lambret
Feb 2, 2022
